| 000 | 01890 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517154403.0 | ||
| 264 | 0 | _c20180226 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2017.05.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartinón-Torres, Federico | |
| 245 | 0 | 0 |
_aReduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial. _h[electronic resource] |
| 260 |
_bVaccine _c06 2017 |
||
| 300 |
_a3548-3557 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aAntibodies, Blocking _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Schedule |
| 650 | 0 | 4 | _aImmunogenicity, Vaccine |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _ximmunology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aNeisseria meningitidis _ximmunology |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSerogroup |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aSafadi, Marco Aurelio P | |
| 700 | 1 | _aMartinez, Alfonso Carmona | |
| 700 | 1 | _aMarquez, Pilar Infante | |
| 700 | 1 | _aTorres, Juan Carlos Tejedor | |
| 700 | 1 | _aWeckx, Lily Yin | |
| 700 | 1 | _aMoreira, Edson Duarte | |
| 700 | 1 | _aMensi, Ilhem | |
| 700 | 1 | _aCalabresi, Marco | |
| 700 | 1 | _aToneatto, Daniela | |
| 773 | 0 |
_tVaccine _gvol. 35 _gno. 28 _gp. 3548-3557 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2017.05.023 _zAvailable from publisher's website |
| 999 |
_c27199300 _d27199300 |
||